In patients with type 2 diabetes, the circulating GPIHBP1 levels might not correlate well with TRL, and rather well‐reflect the microvascular complications, such diabetic retinopathy and diabetic kidney disease. Here, GPIHBP1 is linked to diabetic kidney disease.